Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients
出版年份 2013 全文链接
标题
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients
作者
关键词
-
出版物
PHARMACOGENOMICS
Volume 14, Issue 16, Pages 1991-1998
出版商
Future Medicine Ltd
发表日期
2013-10-03
DOI
10.2217/pgs.13.185
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The relationship of Vascular endothelial growth factor gene polymorphisms and clinical outcome in advanced gastric cancer patients treated with FOLFOX: VEGF polymorphism in gastric cancer
- (2013) Sung Yong Oh et al. BMC CANCER
- VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
- (2013) M Scartozzi et al. BRITISH JOURNAL OF CANCER
- Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
- (2012) Astrid A.M. Van der Veldt et al. CANCER CELL
- VEGF -634C/G Genotype is Predictive of Long-term Survival after Treatment with a Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
- (2012) Takao Tamura et al. International Journal of Medical Sciences
- Prognostic significance of vascular endothelial growth factor immunohistochemical expression in gastric cancer: a meta-analysis
- (2012) Ling Peng et al. MOLECULAR BIOLOGY REPORTS
- Immunohistochemical expression of VEGF predicts response to platinum based chemotherapy in patients with epithelial ovarian cancer
- (2011) G. K. Siddiqui et al. ANGIOGENESIS
- Tumor angiogenesis as prognostic and predictive marker for chemotherapy dose-intensification efficacy in high-risk breast cancer patients within the WSG AM-01 trial
- (2011) Oleg Gluz et al. BREAST CANCER RESEARCH AND TREATMENT
- Pharmacogenetic Angiogenesis Profiling for First-line Bevacizumab plus Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer
- (2011) A. Gerger et al. CLINICAL CANCER RESEARCH
- Inducible nitric oxide synthase expression correlates with angiogenesis, lymphangiogenesis, and poor prognosis in gastric cancer patients
- (2011) Wei Zhang et al. HUMAN PATHOLOGY
- Genetics of VEGF Serum Variation in Human Isolated Populations of Cilento: Importance of VEGF Polymorphisms
- (2011) Daniela Ruggiero et al. PLoS One
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The predictive value of genetic variations in the vascular endothelial growth factor A gene in metastatic colorectal cancer
- (2010) T F Hansen et al. PHARMACOGENOMICS JOURNAL
- VEGF −460T → C polymorphism and its association with VEGF expression and outcome to FOLFOX-4 treatment in patients with colorectal carcinoma
- (2010) M-H Chen et al. PHARMACOGENOMICS JOURNAL
- Microvessel density and the association with single nucleotide polymorphisms of the vascular endothelial growth factor receptor 2 in patients with colorectal cancer
- (2010) Torben Frøstrup Hansen et al. VIRCHOWS ARCHIV
- Novel Perspectives for the Treatment of Gastric Cancer: From a Global Approach to a Personalized Strategy
- (2010) Mario Scartozzi et al. Current Oncology Reports
- Angiogenesis and Lymphangiogenesis of Gastric Cancer
- (2010) Yasuhiko Kitadai Journal of Oncology
- Contribution of HIF-1 and drug penetrance to oxaliplatin resistance in hypoxic colorectal cancer cells
- (2009) D L Roberts et al. BRITISH JOURNAL OF CANCER
- Influence of theVEGF-A936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer
- (2009) Jean-Louis Formento et al. PHARMACOGENOMICS
- Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
- (2008) David Cunningham et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started